![Hong Ma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hong Ma
Technik-/Wissenschafts-/F&E-Leiter bei
CARSGEN THERAPEUTICS HOLDINGS LIMITED
Profil
Hong Ma is currently a Member at the American Society of Hematology and a Senior Vice President-Clinical Development at CARsgen Therapeutics Holdings Ltd. In the past, he worked as a Director-Clinical Development at Bellicum Pharmaceuticals, Inc., Director-Clinical Operations at Endocyte, Inc., and Senior Medical Director at Immatics US, Inc. Dr. Ma holds an MBA degree from the University of Georgia, a graduate degree from Central South University, and an undergraduate degree from Central South University.
Aktive Positionen von Hong Ma
| Unternehmen | Position | Beginn |
|---|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2018 |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | 01.01.2016 |
Ehemalige bekannte Positionen von Hong Ma
| Unternehmen | Position | Ende |
|---|---|---|
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2018 |
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.05.2016 |
| ENDOCYTE, INC. | Corporate Officer/Principal | 01.07.2014 |
Ausbildung von Hong Ma
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
Central South University
 Central South University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Health Technology |
CARsgen Therapeutics Holdings Ltd.
 CARsgen Therapeutics Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
